Form 6K Immuron Ltd ADR For: 9 February
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immuron Ltd ADR (IMRN)
Immuron Ltd ADR stock price live, this page displays NASDAQ IMRN stock exchange data. View the IMRN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immuron Ltd ADR real time stock price chart below.
What Is the Immuron Ltd ADR Stock Price Today?
The Immuron Ltd ADR stock price today is 0.720.
What Is the Stock Symbol for Immuron Ltd ADR?
The stock symbol for Immuron Ltd ADR is ""IMRN.""
What Stock Exchange Does Immuron Ltd ADR Trade On?
Immuron Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Immuron Ltd ADR a Good Stock to Buy?
Determining whether Immuron Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMRN quote. (ISIN: US45254U1016) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Immuron Ltd ADR Stock Price Today?
The Immuron Ltd ADR stock price today is 0.720.
What Is the Stock Symbol for Immuron Ltd ADR?
The stock symbol for Immuron Ltd ADR is ""IMRN.""
What Stock Exchange Does Immuron Ltd ADR Trade On?
Immuron Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Immuron Ltd ADR a Good Stock to Buy?
Determining whether Immuron Ltd ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMRN quote. (ISIN: US45254U1016) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
Fair Value
An estimate of a Immuron's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.720
0.749
52 wk Range
0.677
2.390
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a Immuron's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7200.749
52 wk Range
0.6772.390
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMRN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Immuron's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.600
Upside
+400.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 6K Immuron Ltd ADR For: 15 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 20 January
- Investing.com
- Form 6K Immuron Ltd ADR For: 12 December
- Investing.com
- Form 6K Immuron Ltd ADR For: 14 January
- Investing.com
- Form 6K Immuron Ltd ADR For: 9 February
- Investing.com
- Form 6K Immuron Ltd ADR For: 20 January
- Investing.com
- Form 6K Immuron Ltd ADR For: 14 January
- Investing.com
- Form 6K Immuron Ltd For: 12 January
- Investing.com
- Form 6K Immuron Ltd ADR For: 16 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Immuron Ltd ADR Company Profile
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers’ diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
Compare IMRN to Peers and Sector
Metrics to compare | IMRN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMRNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −8.6x | −0.5x | |
PEG Ratio | −0.07 | −0.14 | 0.00 | |
Price/Book | 1.2x | 5.9x | 2.6x | |
Price / LTM Sales | 1.3x | 17.8x | 3.3x | |
Upside (Analyst Target) | - | 197.1% | 45.6% | |
Fair Value Upside | Unlock | −8.5% | 4.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.600
(+400.06% Upside)
Earnings
Latest Release
Dec 03, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Immuron (IMRN) Stock Price Today?
The Immuron stock price today is 0.720 USD.
What Stock Exchange Does Immuron Trade On?
Immuron is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Immuron?
The stock symbol for Immuron is "IMRN."
What Is the Immuron Market Cap?
As of today, Immuron market cap is 6.660M USD.
What Is Immuron's Earnings Per Share (TTM)?
The Immuron EPS (TTM) is -0.023.
When Is the Next Immuron Earnings Date?
Immuron will release its next earnings report on Mar 04, 2026.
From a Technical Analysis Perspective, Is IMRN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Immuron Stock Split?
Immuron has split 0 times.
How Many Employees Does Immuron Have?
Immuron has 7 employees.
What is the current trading status of Immuron (IMRN)?
As of Feb 19, 2026, Immuron (IMRN) is trading at a price of 0.720 USD, with a previous close of 0.704 USD. The stock has fluctuated within a day range of 0.720 USD to 0.749 USD, while its 52-week range spans from 0.677 USD to 2.390 USD.
What Is Immuron (IMRN) Price Target According to Analysts?
The average 12-month price target for Immuron is 3.600 USD, with a high estimate of 3.60045226 USD and a low estimate of 3.60045226 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +400.06% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.